BioFab
Reducing organ transplantation waiting list by providing bio-generates organs
- Stage Prototype Ready
- Industry Biotechnology
- Location Lima, Peru
- Currency USD
- Founded December 2015
- Employees 10
- Incorporation Type C-corp
- Website biofab.com.pe
Company Summary
BioFab extend peoples lives with a process that starts with our Organ bank built on transformed stem cells extracted from the umbilical cord, third molar and or fat tissue, to later "print" an scaffold organ on a 3D printer and inoculate it with extracted and differentiated stem cells.
We firmly believe in replacing organs as a viable way for life expansion. Either genetics or age our organs deteriorate and end up failing our body.
Team
Advisors
-
Cadia Secondary Market ExchangeUnconfirmed
Previous Investors
-
StartUP ChileUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.